Alzprotect
Biopharmaceutical company which develop new bioactive molecules for the treatment of neurodegenerative diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€56—84m (Dealroom.co estimates Jan 2018.)
Company register number 501096838
Loos Hauts-de-France (HQ)
Authorizing premium user...